We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
The 2023-2028 Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments in the United States
Price data last checked 93 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B0BLR565L7
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
97% match
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in the United States
£520.00
22 Jan 2026
97% match
The 2023-2028 Outlook for Liver Health Supplements in the United States
£520.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Antiviral Drugs in the United States
£520.00
30 Jan 2026
96% match
The 2023-2028 Outlook for Liver Cirrhosis Drugs in India
£515.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
£520.00
29 Jan 2026
96% match
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
£520.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
£520.00
28 Jan 2026
96% match
The 2023-2028 Outlook for Anticoagulant Reversal Drugs in the United States
£520.00
01 Feb 2026
96% match
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
£520.00
25 Jan 2026
96% match
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
£520.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
£520.00
07 Feb 2026
96% match
The 2023-2028 Outlook for Anticoagulant Drugs in the United States
£520.00
01 Feb 2026
96% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Lipopeptide MRSA Drugs in the United States
£520.00
13 Feb 2026
96% match
The 2023-2028 Outlook for Antifungal Drugs in the United States
£520.00
10 Dec 2025
96% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
£520.00
03 Feb 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
£520.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Atopic Dermatitis Drugs in the United States
£520.00
26 Jan 2026
96% match
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Over the Counter Drugs in the United States
£520.00
10 Dec 2025
96% match
The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in the United States
£520.00
31 Jan 2026
96% match
The 2023-2028 Outlook for Hyperpigmentation Disorders Treatments in the United States
£520.00
13 Jan 2026
96% match
The 2023-2028 Outlook for Topical Antiseptic Medications in the United States
£520.00
30 Jan 2026